On Tuesday, January 27, C-Path’s Translational Therapeutics Accelerator will host its newest 2026 Funding Opportunities Webinar to unveil the 2026 global Request for Proposals (RFP).
Our initiative, designed to advance novel therapeutics through the challenging drug development process, will feature a comprehensive approach to funding and support. Whether your research focuses on cutting-edge protein-based therapeutics (PBTs), gene-based therapies, or early-stage small molecule drug development, this RFP aims to provide the crucial resources needed to bridge the gap from lab discoveries to potential clinical applications.
In this webinar, we will cover:
- An overview of the RFP, encompassing both large and small molecules;
- Detailed information about the types of projects eligible for funding, including those for novel protein-based therapeutics, gene-based therapies and small molecule lead optimization, through IND-enabling studies;
- Eligibility criteria and application procedures for this funding opportunity;
- Insights into how the accelerator supports projects through the drug development valley of death to enhance licensing prospects.
The session will include a live Q&A to address your questions and provide further clarity on how to make the most of this unique opportunity. Don’t miss this chance to learn how this year’s RFP can support your innovative research and propel it towards impactful therapeutic solutions.
